TERT and glioblastoma: Interestingly, TERT promoter mutations are frequently detected in tumors originating from normal cells with low rates of self-renewal, such as glioblastoma (83%), melanoma (71%), UBC (67%), UTUC (47%), and hepatocellular carcinoma (HCC) (44%) (23).